Oral clonidine provocative test in the diagnosis of growth hormone deficiency in childhood: should we make the timing uniform? [0.03%]
童年生长激素缺乏诊断中的克隆滴美口服激发试验：我们需要统一时间吗？
Fiorella Galluzzi,Stefano Stagi,Maria Parpagnoli et al.
Fiorella Galluzzi et al.
Introduction: Oral clonidine is one of the most frequent drugs used for the diagnosis of growth hormone deficiency (GHD), but the duration of the test, depending on which European centres use it, is not uniform and can va...
Psychosocial functioning, self-perception and body image and their auxologic correlates in growth hormone and oestrogen-treated young adult women with Turner syndrome [0.03%]
青春期延长生长激素和雌激素治疗对Turner综合征年轻女性心理社会功能、自我认识及体像的辅助作用及相关影响因素的研究
Katrien Lagrou,Christelle Froidecoeur,Francisca Verlinde et al.
Katrien Lagrou et al.
Background: Few data are available on the psychosocial status of growth hormone (GH) and oestrogen treated women with Turner syndrome (TS). In this study, we evaluated psychosocial functioning, self-concept and body image...
A girl with a novel splice site mutation in VDR supports the role of a ligand-independent VDR function on hair cycling [0.03%]
携带VDR新异种剪接位点突变的女性支持了配体非依赖型维生素D受体在毛发周期中的作用
Paravee Katavetin,Pisut Katavetin,Suttipong Wacharasindhu et al.
Paravee Katavetin et al.
Mutations in vitamin D receptor (VDR) cause hereditary vitamin D resistant rickets (HVDRR). We reported a Thai girl with HVDRR, presenting with an early onset of rickets and partial alopecia. She was a product of a consanguineous couple. Mu...
Case Reports
Hormone research. 2006;66(6):273-6. DOI:10.1159/000095546 2006
Hypercalcaemia in relapsed medulloblastoma 8 years post-diagnosis; evidence to support PTHrP production by medulloblastoma cells [0.03%]
复发性髓母细胞瘤诊断后八年出现高血钙的病例；支持髓母细胞瘤细胞产生PTHrP的证据
P Dharmaraj,S Ball,H Johnstone et al.
P Dharmaraj et al.
Background: A 19-year-old male presented with symptomatic hypercalcaemia as the first manifestation of relapsed metastatic medulloblastoma. Management at the time of the initial presentation 8 years earlier was with surgi...
Case Reports
Hormone research. 2006;66(6):268-72. DOI:10.1159/000095545 2006
Genetic disorders in the growth hormone - insulin-like growth factor-I axis [0.03%]
生长激素-胰岛素样生长因子I轴的遗传异常
M J E Walenkamp,J M Wit
M J E Walenkamp
In the last few years, our knowledge of genetically determined causes of short stature has greatly increased by reports of challenging patients, who offered the opportunity to study genes that play a role in growth. Since the first paper th...
Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density [0.03%]
生长激素缺乏及其替代治疗在库欣病、泌乳素瘤和无功能垂体腺瘤患者中的作用：对身体组成、糖代谢、脂质状况及骨矿物质密度的影响
A Colson,A M Brooke,D Walker et al.
A Colson et al.
Background/aims: This study was designed to determine whether previous Cushing's disease (CD) or prolactinoma (PRL) could exert adverse effects additional to those of growth hormone (GH) deficiency as a consequence of var...
Effects of early high-dose levothyroxine treatment on auditory brain event-related potentials at school entry in children with congenital hypothyroidism [0.03%]
早期大剂量左旋甲状腺素治疗对学龄前先天性甲减患儿听觉脑干听觉诱发位的影响研究
S Marti,M Alvarez,J Simoneau-Roy et al.
S Marti et al.
Aims: We tested whether brain event-related potentials (ERPs) are normal in children with congenital hypothyroidism (CH) after early high-dose levothyroxine treatment. ...
Comparative Study
Hormone research. 2006;66(5):240-8. DOI:10.1159/000095069 2006
Correlation between serum osteoprotegerin and biomarkers of bone metabolism during anti-thyroid treatment in patients with Graves' disease [0.03%]
Graves病患者抗甲状腺治疗过程中血清osteoprotegerin与骨代谢标志物的相关性研究
Yasuhiro Mochizuki,Nobuyuki Banba,Yoshiyuki Hattori et al.
Yasuhiro Mochizuki et al.
Bone turnover is increased in favor of resorption in hyperthyroid patients. We aimed to examine whether osteoprotegerin (OPG), which has an inhibitory effect on osteoclasts, is correlated with any biomarkers for bone turnover in Graves' dis...
Comparative Study
Hormone research. 2006;66(5):236-9. DOI:10.1159/000095068 2006
Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment [0.03%]
特异的生长激素（GH）分泌药理学试验中，血清GH截断值的不同取决于所用的测定方法。第一年治疗期间生长速度评分的临床验证结果
E A Chaler,M A Rivarola,B Guerci et al.
E A Chaler et al.
Background: The serum GH cut-off value for pharmacological tests of GH secretion (PhT GH) depends on the type of test and also on the method used for determining serum GH. Cut-off serum GH values as different as 5-10 ng/m...
Comparative Study
Hormone research. 2006;66(5):231-5. DOI:10.1159/000095005 2006